KRRO vs STE · rev $2.3M vs P/E 25, rev $5.46B
Korro Bio, Inc. (KRRO) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported KRRO revenue for 2024-12-31 was $2.3M. Net income was -$83.6M. KRRO currently screens at market cap $159.8M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
KRRO currently screens at market cap $159.8M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the KRRO and STE stock pages for the full models.
Not investment advice.